Heart transplantation overview: Difference between revisions
Ifrah Fatima (talk | contribs) No edit summary |
Ifrah Fatima (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
'''Heart transplantation''' or '''cardiac transplantation''', is a surgical [[organ transplant|transplant]] procedure performed on patients with end-stage [[heart failure]] or severe [[coronary artery disease]] | '''Heart transplantation''' or '''cardiac transplantation''', is a surgical [[organ transplant|transplant]] procedure performed on patients with end-stage [[heart failure]] or severe [[coronary artery disease]] when medical and device therapy have failed. The most common procedure is to take a working [[heart]] from a recently deceased organ donor ([[allograft]]) and implant it into the patient. The patient's own heart may either be removed ([[heart transplantation#Orthotopic procedure|orthotopic procedure]]) or, less commonly, left in to support the donor heart ([[heart transplantation#Heterotopic procedure|heterotopic procedure]]). | ||
Cardiac transplantation is reserved for patients with end-stage congestive heart failure despite all interventions. 1 year survival is 80%, and 5 year survival is 60%. Lifelong immunosuppressive therapy is used to prevent (or postpone) rejection, but increases the risk for opportunistic infections and malignancies. | Cardiac transplantation is reserved for patients with end-stage congestive heart failure despite all interventions. 1 year survival is 80%, and 5 year survival is 60%. Lifelong immunosuppressive therapy is used to prevent (or postpone) rejection, but increases the risk for opportunistic infections and malignancies. | ||
Revision as of 18:40, 9 July 2020
|
Heart transplantation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Heart transplantation overview On the Web |
|
American Roentgen Ray Society Images of Heart transplantation overview |
|
Risk calculators and risk factors for Heart transplantation overview |
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D.; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [1]Ifrah Fatima, M.B.B.S[2]
Overview
Heart transplantation or cardiac transplantation, is a surgical transplant procedure performed on patients with end-stage heart failure or severe coronary artery disease when medical and device therapy have failed. The most common procedure is to take a working heart from a recently deceased organ donor (allograft) and implant it into the patient. The patient's own heart may either be removed (orthotopic procedure) or, less commonly, left in to support the donor heart (heterotopic procedure).
Cardiac transplantation is reserved for patients with end-stage congestive heart failure despite all interventions. 1 year survival is 80%, and 5 year survival is 60%. Lifelong immunosuppressive therapy is used to prevent (or postpone) rejection, but increases the risk for opportunistic infections and malignancies.
The indications for heart transplantation include severe hemodynamic compromise due to heart failure which equires IV inotropic support to maintain adequate organ perfusion; a peak Vo2 <10 ml/kg/min; NYHA Class IV symptoms not amenable to any other intervention; or recurrence of symptomatic ventricular arrhythmias refractory to all therapeutic intervention.